Comparative enzymology of 11β-hydroxysteroid dehydrogenase type 1 from six species

Journal of Molecular Endocrinology

Volumn 35, Issue 1, 2005, Pages 89-101

  Arampatzis, Spyridon ^b   Kadereit, Bert ^b   Schuster, Daniela ^a   Balazs, Zoltan ^b   Schweizer, Roberto A S ^b   Frey, Felix J ^b   Langer, Thierry ^a   Odermatt, Alex ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 7 OXOCHOLESTEROL; 7BETA HYDROXYCHOLESTEROL; ABIETIC ACID; CARBENOXOLONE; CHENODEOXYCHOLIC ACID; CORTISONE; DEHYDROCORTICOSTERONE; ENZYME INHIBITOR; FLAVANONE; FLAVANONE DERIVATIVE; GLYCYRRHETINIC ACID; HYDROCORTISONE; 11-DEHYDROCORTICOSTERONE; COMPLEMENTARY DNA; CORTICOSTERONE; DRUG DERIVATIVE; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME BINDING; ENZYME MECHANISM; ENZYME SUBSTRATE; ENZYMOLOGY; EXPERIMENTATION; GUINEA PIG; HAMSTER; HUMAN; HYDROPHOBICITY; METABOLIC SYNDROME X; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; STEREOSPECIFICITY; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; DOG; DRUG ANTAGONISM; ENZYME ACTIVE SITE; ENZYME SPECIFICITY; GENETICS; IN VITRO STUDY; KINETICS; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; SEQUENCE HOMOLOGY;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CATALYTIC DOMAIN; CELL LINE; CLONING, MOLECULAR; CORTICOSTERONE; CORTISONE; CRICETINAE; DNA, COMPLEMENTARY; DOGS; ENZYME INHIBITORS; GUINEA PIGS; HUMANS; KINETICS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; RATS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SPECIES SPECIFICITY; SUBSTRATE SPECIFICITY;

EID: 23844467917     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01736     Document Type: Article

References (47)

1. Agarwal AK, Monder C, Eckstein B & White PC 1989 Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. Journal of Biological Chemistry 264 18939-18943.
2. Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M et al. 2003 Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144 4755-4762.
3. Atanasov AG, Tam S, Rocken JM, Baker ME & Odermatt A 2003 Inhibition of 11 beta-hydroxysteroid dehydrogenase type 2 by dithiocarbamates. Biochemical and Biophysical Research Communications 308 257-262.
4. Atanasov AG, Nashev LG, Schweizer RA, Frick C & Odermatt A 2004 Hexose-6-phosphate dehydrogenase determines the reaction direction of 11 beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Letters 571 129-133.
5. Barf T, Vallgarda J, Emond R, Haggstrom C, Kurz G, Nygren A, Larwood V, Mosialou E, Axelsson K, Olsson R et al. 2002 Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11 beta-hydroxysteroid dehydrogenase type 1. Journal of Medicinal Chemistry 45 3813-3815.
6. Barnes PJ 1998 Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clinical Science (London) 94 557-572.
7. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN & Bourne PE 2000 The Protein Data Bank. Nucleic Acids Research 28 235-242.
8. Brown AJ, Watts GF, Burnett JR, Dean RT & Jessup W 2000 Sterol 27-hydroxylase acts on 7-ketocholesterol in human atherosclerotic lesions and macrophages in culture. Journal of Biological Chemistry 275 27627-27633.
9. 50) of an enzymatic reaction. Biochemical Pharmacology 22 3099-3108.
10. Chrousos GP 2004 Is 11 beta-hydroxysteroid dehydrogenase type 1 a good therapeutic target for blockade of glucocorticoid actions? PNAS 101 6329-6330.
11. Dalle M & Delost P 1976 Plasma and adrenal cortisol concentrations in foetal, newborn and mother guinea-pigs during the perinatal period. Journal of Endocrinology 70 207-214.
12. De Bosscher K, Vanden Berghe W & Haegeman G 2003 The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocrine Reviews 24 488-522.
13. Diederich S, Grossmann C, Hanke B, Quinkler M, Herrmann M, Bahr V & Oelkers W 2000 In the search for specific inhibitors of human 11 beta-hydroxysteroid-dehydrogenases (11 beta-HSDs), chenodeoxycholic acid selectively inhibits 11 beta-HSD-I. European Journal of Endocrinology 142 200-207.
14. Dyrszka H, Chen T, Salen G & Mosbach EH 1975 Toxicity of chenodeoxycholic acid in the rhesus monkey. Gastroenterology 69 333-337.
15. Frey FJ, Odermatt A & Frey BM 2004 Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension. Current Opinion in Nephrology and Hypertension 13 451-458.
16. Hult M, Elleby B, Shafqat N, Svensson S, Rane A, Jornvall H, Abrahmsen L & Oppermann U 2004 Human and rodent type 1 11 beta-hydroxysteroid dehydrogenases are 7 beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism. Cellular and Molecular Life Sciences 61 992-999.
17. Kannisto K, Pietilainen KH, Ehrenborg E, Rissanen A, Kaprio J, Hamsten A & Yki-Jarvinen H 2004 Overexpression of 11β-hydroxysteroid dehydrogenase-1 in adipose tissue Is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins. Journal of Clinical Endocrinology and Metabolism 89 4414-4421.
18. Keightley MC, Curtis AJ, Chu S & Fuller PJ 1998 Structural determinants of cortisol resistance in the guinea pig glucocorticoid receptor. Endocrinology 139 2479-2485.
19. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR et al. 1997 11 beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. PNAS 94 14924-14929.
20. Lindsay RS, Wake DJ, Nair S, Bunt J, Livingstone DE, Permana PA, Tataranni PA & Walker BR 2003 Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. Journal of Clinical Endocrinology and Metabolism 88 2738-2744.
21. Lyons MA & Brown AJ 1999 7-Ketocholesterol. International Journal of Biochemistry and Cell Biology 31 369-375.
22. Maeda Y, Nagatomo H, Uchiyama F, Nagatomo J, Yamada M, Shiotsuki H, Ohta Y, Sato S, Kai MH, Kondo KH et al. 2002 A comparative study of the conversion of 7-hydroxycholesterol in rabbit, guinea pig, rat, hamster, and chicken. Steroids 67 703-708.
23. Masuzaki H & Flier JS 2003 Tissue-specific glucocorticoid reactivating enzyme, 11 betahydroxysteroid dehydrogenase type 1 (11 beta-HSD1) - a promising drug target for the treatment of metabolic syndrome. Current Drug Targets. Immune, Endocrine and Metabolic Disorders 3 255-262.
24. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR & Flier JS 2001 A transgenic model of visceral obesity and the metabolic syndrome. Science 294 2166-2170.
25. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ et al. 2003 Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. Journal of Clinical Investigation 112 83-90.
26. Morris DJ, Souness GW, Latif SA, Hardy MP & Brem AS 2004 Effect of chenodeoxycholic acid on 11 beta-hydroxysteroid dehydrogenase in various target tissues. Metabolism 53 811-816.
27. Morton NM, Paterson JM, Masuzaki H, Holmes MC, Staels B, Fievet C, Walker BR, Flier JS, Mullins JJ & Seckl JR 2004 Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53 931-938.
28. Odermatt A, Arnold P, Stauffer A, Frey BM & Frey FJ 1999 The N-terminal anchor sequences of 11 beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. Journal of Biological Chemistry 274 28762-28770.
29. Okun R, Goldstein LI, Van Gelder GA, Goldenthal EI, Wazeter FX & Giel RG 1982 National Cooperative Gallstone Study: nonprimate toxicology of chenodeoxycholic acid. Journal of Toxicology and Environmental Health 9 727-741.
30. Oppermann UC, Netter KJ & Maser E 1995 Cloning and primary structure of murine 11 betahydroxysteroid dehydrogenase/microsomal carbonyl reductase. European Journal of Biochemistry 227 202-208.
31. Ottenweller JE, Tapp WN, Burke JM & Natelson BH 1985 Plasma cortisol and corticosterone concentrations in the golden hamster (Mesocricetus auratus). Life Sciences 37 1551-1558.
32. Paterson JM, Morton NM, Fievet C, Kenyon CJ, Holmes MC, Staels B, Seckl JR & Mullins JJ 2004 Metabolic syndrome without obesity: hepatic overexpression of 11 beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. PNAS 101 7088-7093.
33. Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC & Grino M 2002 Expression of the mRNA coding for 11 beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. Journal of Clinical Endocrinology and Metabolism 87 2701-2705.
34. Pu X & Yang K 2000 Guinea pig 11 beta-hydroxysteroid dehydrogenase type 1: primary structure and catalytic properties. Steroids 65 148-156.
35. Quattropani C, Vogt B, Odermatt A, Dick B, Frey BM & Frey FJ 2001 Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis. Journal of Clinical Investigation 108 1299-1305.
36. Rajan V, Chapman KE, Lyons V, Jamieson P, Mullins JJ, Edwards CR & Seckl JR 1995 Cloning, sequencing and tissue-distribution of mouse 11 beta-hydroxysteroid dehydrogenase-1 cDNA. Journal of Steroid Biochemistry and Molecular Biology 52 141-147.
37. Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R & Olsson T 2002 Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity. Journal of Clinical Endocrinology and Metabolism 87 3330-3336.
38. Rauz S, Cheung CM, Wood PJ, Coca-Prados M, Walker EA, Murray PI & Stewart PM 2003 Inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 lowers intraocular pressure in patients with ocular hypertension. Quarterly Journal of Medicine 96 481-490.
39. Sandeep TC & Walker BR 2001 Pathophysiology of modulation of local glucocorticoid levels by 11 beta-hydroxysteroid dehydrogenases. Trends in Endocrinology and Metabolism 12 446-453.
40. Sandeep TC, Yau JL, MacLullich AM, Noble J, Deary IJ, Walker BR & Seckl JR 2004 11 beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. PNAS 101 6734-6739.
41. Schweizer RA, Atanasov AG, Frey BM & Odermatt A 2003 A rapid screening assay for inhibitors of 11 beta-hydroxysteroid dehydrogenases (11 beta-HSD): flavanone selectively inhibits 11 beta-HSD1 reductase activity. Molecular and Cellular Endocrinology 212 41-49.
42. Schweizer RA, Zurcher M, Balazs Z, Dick B & Odermatt A 2004 Rapid hepatic metabolism of 7-ketocholesterol by 11β-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme. Journal of Biological Chemistry 279 18415-18424.
43. Stauffer AT, Rochat MK, Dick B, Frey FJ & Odermatt A 2002 Chenodeoxycholic acid and deoxycholic acid inhibit 11 beta-hydroxysteroid dehydrogenase type 2 and cause cortisol-induced transcriptional activation of the mineralocorticoid receptor. Journal of Biological Chemistry 277 26286-26292.
44. Stewart PM & Krozowski ZS 1999 11 beta-hydroxysteroid dehydrogenase. Vitamins and Hormones 57 249-324.
45. Tannin GM, Agarwal AK, Monder C, New MI & White PC 1991 The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. Journal of Biological Chemistry 266 16653-16658.
46. Valsamakis G, Anwar A, Tomlinson JW, Shackleton CH, McTernan PG, Chetty R, Wood PJ, Banerjee AK, Holder G, Barnett AH et al. 2004 11 beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 89 4755-4761.
47. Wolber G & Langer T 2005 LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling 45 160-169.